Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Dysport trial in adult upper limb spasticity after stroke or traumatic brain injury
2010-019069-28Phase 3Completed
- Sponsor
- Ipsen
- Start
- Apr 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in upper extremity spasticity comparing Dysport with Placebo (2 arms). Primary endpoint: Change from baseline in Modified Ashworth Scale in the primary targeted muscle group at Week 4. Started Apr 2011; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
upper extremity spasticity
Beyond the preview
Go deeper on 2010-019069-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019069-28.